Cystic Fibrosis Clinical Trials 2024

Cystic Fibrosis Clinical Trials 2024

Cystic Fibrosis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in cystic fibrosis clinical trials today.

Cystic Fibrosis Clinical Trials

Here are the 6 most popular medical studies for cystic fibrosis

Popular filter options for cystic fibrosis trials

CF Clinical Trials

View 71 CF medical studies.

Bronchiectasis Clinical Trials

View 6 Bronchiectasis medical studies.

CFTR Positive Clinical Trials

View 18 CFTR positive medical studies.

Phase 3 Cystic Fibrosis Clinical Trials

View 76 phase 3 cystic fibrosis medical studies.

Cystic Fibrosis Clinical Trials With No Placebo

View 76 cystic fibrosis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to cystic fibrosis

What are the top hospitals conducting cystic fibrosis research?

In the ever-evolving landscape of cystic fibrosis research, several top-notch hospitals are leading the way with their groundbreaking clinical trials. Boston Children's Hospital in Boston is at the forefront, currently conducting an impressive 13 active trials for cystic fibrosis. Their commitment to this cause spans over time and includes a remarkable 57 all-time trials since their first recorded investigation in 2008. Similarly, Nationwide Children's Hospital in Columbus has established itself as a powerhouse in cystic fibrosis research with equal enthusiasm, boasting 13 ongoing trials and an expansive history of 66 completed studies dating back to their inaugural trial in 2005.

Meanwhile, down south at the University of Alabama at Birmingham, researchers are diligently working on finding new treatments for cystic fibrosis through their involvement in 12 active clinical trials. With a strong track record of dedication to this field, they have conducted a total of 56 previous investigations since embarking upon their first trial in 2004. In Kansas City, the University of Kansas Medical Center joins these efforts by currently running ten ongoing cystic fibrosis trials while having accomplished valuable insights from prior experimentation spanning across thirty-five studies starting from its pioneering research commenced fifteen years agoin2005.

Furthermore adding itself proudly into this group is National Jewish Health located amidst Denver’s beautiful surroundings; here they showcase ten vibrant current initiatives examining novel approaches towards CF management meanwhile keeping up pace with seventy-six earlier trails from venturing into such investigative endeavors since officially commencing it around fifteen years ago until sustaining present times eleven years after inception; not only do these promising developments provide hope but also serve as motivation driving us closer towards better care prospects for individuals affected by CF nationwide.

These esteemed institutions embody optimism and progress when it comes to combating cystic fibrosis—a complex genetic disorder affecting multiple organs including lungs and digestive system—ultimately striving towards improved quality-of-life options available for patients worldwide.

Which are the best cities for cystic fibrosis clinical trials?

Pittsburgh, Pennsylvania; Boston, Massachusetts; Indianapolis, Indiana; Birmingham, Alabama; and Minneapolis, Minnesota are among the best cities for cystic fibrosis clinical trials. These cities have a significant number of active trials focused on studying various treatments like VX-121/TEZ/D-IVA, Stage 1/2a Arm 3, sodium nitrite, β-lactam Only (Non-AG), Imipenem/cilastatin/relebactam, Symdeko, Ivacaftor, and more. With their commitment to research and development in cystic fibrosis treatment options, these cities offer individuals with this condition access to cutting-edge clinical studies that pave the way for advancements in care and improved outcomes.

Which are the top treatments for cystic fibrosis being explored in clinical trials?

Clinical trials for cystic fibrosis have brought forth a range of promising treatments. One standout contender is VX-121/TEZ/D-IVA, currently being explored in four active trials and showing potential since its first listing in 2021. Additionally, ELX/TEZ/IVA has caught the attention of researchers with three ongoing trials and an impressive track record of 19 all-time cystic fibrosis studies since its introduction in 2018. Another avenue being explored is the initiation of CFTR modulator therapy, with two active trials aiming to uncover new possibilities for treating this condition that affect many individuals worldwide. Trikafta and exercise interventions also hold promise as they undergo evaluation through clinical investigation for their efficacy in managing cystic fibrosis symptoms and improving patient outcomes.

What are the most recent clinical trials for cystic fibrosis?

Exciting developments are underway in the realm of cystic fibrosis treatment, with recent clinical trials offering hope for improved outcomes. One such trial involves Rifaximin 550 MG Oral Tablet [XIFAXAN]. This medication has progressed to Phase 2 and Phase 3 studies, demonstrating potential benefits for individuals with cystic fibrosis. Another promising avenue is the use of VNZ/TEZ/D-IVA, currently in Phase 3 testing, which shows promise as a therapeutic option. Additionally, KB407 (Nebulization) has entered Phase 1, highlighting its potential role in managing this condition. These advancements signal progress toward better treatment options for those affected by cystic fibrosis.

What cystic fibrosis clinical trials were recently completed?

Several recent clinical trials have made significant strides in the pursuit of better treatments for cystic fibrosis. In September 2022, AbbVie successfully completed a trial evaluating Galicaftor's potential effectiveness. Vertex Pharmaceuticals Incorporated also achieved milestones with two trials: one investigating VX-121/TEZ/D-IVA in July 2022 and another exploring ELX/TEZ/IVA in May 2022. Nabriva Therapeutics AG completed a trial on Lefamulin in March 2022, while Insmed Incorporated concluded their Brensocatib study in November 2021. These advancements highlight ongoing efforts to improve outcomes and quality of life for individuals living with cystic fibrosis.